Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NYSE:NVS’

GlaxoSmithKline plc (ADR) (NYSE:GSK)

This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)

What’s a smart GlaxoSmithKline plc (ADR) (NYSE:GSK) investor to do? In the financial world, there are many methods market participants can use......(read more)
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): The Biggest Winners of the FDA’s Breakthrough Designation

Designed as a way to bring potentially life-changing drugs to pharmacy shelves faster than ever, the Food and Drug Administration Safety and Innovation......(read more)
Novartis AG (ADR) (NYSE:NVS)

Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?

As an investor in the health care sector, it can sometimes feel like everything — and everyone — is out to get you. The ongoing threat of......(read more)
Novartis AG (ADR) (NYSE:NVS)

Hedge Funds Are Buying Novartis AG (ADR) (NVS)

In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets. A couple of the best......(read more)
Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. (LLY), Novartis AG (ADR) (NVS), Shire PLC (ADR) (SHPG): A Closer Look at the Controversial Market Growth of ADHD Treatments

The existence of ADHD, or attention deficit hyperactivity disorder, has been a hot-button topic since the 1970s. On one hand, there are scientists who......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY), Pacific Biosciences of California (PACB), Astex Pharmaceuticals, Inc. (ASTX): 3 Humongous Health-Care Stocks This Week

While the overall market muddled through the past five days, some stocks were on fire. Here are three health-care stocks experiencing humongous gains......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN) and Onyx Pharmaceuticals, Inc. (ONXX): Half a Billion Dollars’ Worth of Drama

A finale has at last arrived for the biotech drama of summer 2013. Amgen, Inc. (NASDAQ:AMGN) announced yesterday that it will buy Onyx Pharmaceuticals......(read more)
Bristol Myers Squibb Co. (NYSE:BMY)

Curis, Inc. (CRIS), Bristol Myers Squibb Co. (BMY), Novartis AG (ADR) (NVS): Can Stopping This Hedgehog Create New Cancer Treatments?

Curis, Inc. (NASDAQ:CRIS) and Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) Genentech unit have stopped a hedgehog — not a spiky little beast, but a......(read more)
GTx, Inc. (NASDAQ:GTXI)

GTx, Inc. (GTXI), Novartis AG (ADR) (NVS): This Week in Biotech

With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
Community Health Systems (NYSE:CYH)

Community Health Systems (CYH), Novartis AG (ADR) (NVS): 7 Things You Need to Know About Obamacare Before 2014

Obamacare. Is. Coming. Well, OK, many parts of the Patient Protection and Affordable Care Act, commonly referred to as Obamacare, have already been implemented......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY), Gilead Sciences, Inc. (GILD): Pop-Worthy Data, Incyte, but Let’s See More

The phase 2 data that Incyte Corporation (NASDAQ:INCY) presented on Wednesday was downright stellar. For a subgroup of the patients, the hazard ratio......(read more)
Sanofi SA (ADR) (NYSE:SNY)

Is Sanofi SA (ADR) (SNY) Going to Burn These Hedge Funds?

If you’re reading this, chances are you’re a Sanofi SA (ADR) (NYSE:SNY) investor, or are considering a position. The following data is crucial......(read more)
Incyte Corporation (NASDAQ:INCY)

Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does Incyte Corporation (INCY) Deserve Its New Valuation?

One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK......(read more)
Incyte Corporation (NASDAQ:INCY)

Novartis AG (ADR) (NVS): Why Incyte Corporation (INCY) Shares Skyrocketed

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)
Pfizer Inc. (NYSE:PFE)

Someone’s Selling Pfizer Inc. (PFE) Shares, Should You?

Pfizer Inc. (NYSE:PFE) is up 13.5% in 2013, but one sect of the market has sold off some shares of late. Who is it? Now, according to many traders, hedge......(read more)
Incyte Corporation (NASDAQ:INCY)

Novartis AG (ADR) (NVS), Amgen, Inc. (AMGN): Incyte Corporation (INCY) Jumps on Jakafi Results

Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic......(read more)
Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc. (BIIB), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Novartis AG (ADR) (NVS): Companies Leading the Fight Against Multiple Sclerosis

It’s a disease that doesn’t often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are......(read more)
Novartis AG (ADR) (NYSE:NVS)

Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar

The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is really beginning to heat up, and it’s offering investors......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS): One Hidden Pharmaceutical Technology for Your Portfolio

Pharmaceutical companies are always looking for competitive advantages. Historically, getting a leg up on the competition has centered on identifying......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern

GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (ARIA), Bristol-Myers Squibb Co (BMY): The Most Important Number for This Drug Launch

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) gave investors a closer look at how the launch of its leukemia drug Iclusig is going when it released second......(read more)
Roche Holding Ltd

Roche Holding Ltd. (ADR) (RHHBY), Novartis AG (ADR) (NVS): Should You Keep an Eye on These Eye Treatment Biotechs?

Investors might want to keep their eyes on the eye care industry, as the battle for eye treatments heats up across the biotech sector. Two eye diseases......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), Novartis AG (ADR) (NVS): Respiratory Drug Maker About to Take Off

Chronic obstructive pulmonary disease (COPD) is America’s third leading cause of death. It is a lung disease caused due to continuous poor airflow as......(read more)
Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. (LLY), Novartis AG (ADR) (NVS): Is This Company Getting Ahead of Itself?

The biotechnology industry is one of the riskiest places to put your money. However, when companies get everything right, the fortunes made there are......(read more)
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

Celgene Corporation (CELG), Novartis AG (ADR) (NVS): Momenta Pharmaceuticals, Inc. (MNTA) Earnings Remind Investors of Growing Pains

The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals......(read more)
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

3 Things You Need to Know From Astex Pharmaceuticals, Inc. (ASTX)’s Q2 Earnings

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open. The company reported a......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Baxter International Inc. (BAX): Can the FDA Make Up Its Mind Already?

It isn’t very often that an agency sometimes accused of over-regulating an industry can be ridiculed for not regulating enough, but that’s......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY) Earnings Cruise on Jakafi Growth

Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings......(read more)
Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc (BIIB), Pfizer Inc. (PFE): Out With the Old, In With the New in Treating MS

Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)‘s recent earnings report is a key confirmation of a shifting market......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Which of These COPD Treatments Will Come Out on Top?

To most people, cigarettes are often associated with lung cancer. However, smoking also causes other severe respiratory problems, such as COPD (chronic......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN): Extremely Expensive Drugs for Extremely Rare Diseases

The biotech industry is known for fast paced acquisitions and rapid market consolidation. Larger pharmaceutical companies headed towards patent cliffs......(read more)
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

Momenta Pharmaceuticals, Inc. (MNTA) Latest to Take Advantage of Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s Patent Woes

The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). In June, it was determined......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE): As Healthcare Demand Rises, So Will This Company’s Profits

The aging population as well as the higher number of people who will receive benefits under new healthcare laws should combine to produce rising profits......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout. Reportedly, four......(read more)
Alkermes Plc (NASDAQ:ALKS)

Alkermes Plc (ALKS), Quest Diagnostics Inc (DGX): This Week in Biotech

With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Novartis AG (ADR) (NYSE:NVS)

A Look at Novartis AG (ADR) (NVS)’ Second Quarter

The story of the second quarter for Novartis AG (ADR) (NYSE:NVS) offered mixed results for investors. The company’s net sales were up 1%, and EPS......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Is the Best Investment?

Amid sluggish sales growth, the Pharmaceutical Industry giants are struggling with declining revenues and profits. Banking on the introduction of new......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK): This Pharmaceutical Company Is Poised for Wellness

Sustainability and a strong pipeline are the two tests that best evaluate a pharmaceutical company. Merck & Co., Inc. (NYSE:MRK) scores high on both......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Pfizer Inc. (PFE): 3 Potential Game Changers for COPD

Over 13 million Americans have it. More than 120,000 of them die every year. Chronic obstructive pulmonary disease, or COPD, stands as the third leading......(read more)
Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ), Novartis AG (ADR) (NVS): Don’t Let Your Attention Defect

Ineffective drugs being sold for billions in global sales. According to an article in the Wall Street Journal, a study in Quebec on 4,000 students (gathering......(read more)
The Boeing Company (NYSE:BA)

The Boeing Company (BA), Lockheed Martin Corporation (LMT) – Pentagon Watch: Where Did Your Tax Dollars Go This Week?

The U.S. military has a reputation as a somewhat secretive organization. But in one respect at least, the Pentagon ranks among our most transparent government......(read more)
Largest Financial Services Companies

Wells Fargo & Co (WFC), Baxter International Inc. (BAX): Obamacare-Inspired Investment Opportunities

Love it or hate it, the Patient Protection and Affordable Care Act — commonly referred to as Obamacare — changes the health care landscape......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY): Don’t Ignore These European Healthcare Stocks

Healthcare stocks have rallied over the past couple years, and for good reason. Not only is the global economy gaining traction, but the demographic trends......(read more)
Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), Novo Nordisk A/S (ADR) (NVO), Johnson & Johnson (JNJ): Can Investors Bet on These 3 Pharma Companies?

According to the World Health Organization, there are 347 million people around the world who suffer from diabetes. It is expected that the death rate......(read more)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Aegerion Pharmaceuticals, Inc. (AEGR), Arena Pharmaceuticals, Inc. (ARNA): Investment Opportunities in Drug Launches

There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-......(read more)
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (JNJ): New Drugs and Better Manufacturing Make This Stock a Buy

Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries. The company maintains a diverse revenue base, a robust......(read more)
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (JNJ): Why Might This Play Shake Up the Cancer-Drug Industry?

Medical firm Johnson & Johnson (NYSE:JNJ) recently announced a private-company acquisition that could have major implications for one of the markets......(read more)
Pfizer Inc. (NYSE:PFE)

Hedge Funds Are Betting On Pfizer Inc. (PFE)

Pfizer Inc. (NYSE:PFE) was in 81 hedge funds’ portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in......(read more)
Idenix Pharmaceuticals Inc (NASDAQ:IDIX)

Idenix Pharmaceuticals Inc (IDIX), GenMark Diagnostics, Inc (GNMK): Horrendous Health-Care Stocks This Week

The overall markets experienced the biggest one-day losses in quite a while this week. But those drops were pocket change compared with these horrendous......(read more)
Myriad Genetics, Inc. (NASDAQ:MYGN)

Myriad Genetics, Inc. (MYGN): Big Pharma’s Intellectual Property Blues

It’s not easy being a biotech company. Every year, the biotech industry pours billions of dollars in research and development costs towards creating......(read more)